A61K 51/1203
In a form not provided for by groups a61k51/1206 - a61k51/1296
Official title: {in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors}
A61K51/1203 (In a form not provided for by groups a61k51/1206 - a61k51/1296) appears on 93 US grants and 114 published applications in this corpus.
Search patents in A61K- Granted patents
- 93
- Published applications
- 114
- Assignees
- 93
- Inventors
- 269
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 4 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 3 |
| 2004 | 0 | 3 |
| 2005 | 1 | 3 |
| 2006 | 2 | 3 |
| 2007 | 3 | 1 |
| 2008 | 1 | 3 |
| 2009 | 0 | 2 |
| 2010 | 0 | 3 |
| 2011 | 2 | 2 |
| 2012 | 1 | 5 |
| 2013 | 2 | 4 |
| 2014 | 2 | 3 |
| 2015 | 6 | 4 |
| 2016 | 3 | 6 |
| 2017 | 4 | 9 |
| 2018 | 3 | 9 |
| 2019 | 5 | 6 |
| 2020 | 4 | 8 |
| 2021 | 4 | 8 |
| 2022 | 6 | 6 |
| 2023 | 1 | 7 |
| 2024 | 3 | 4 |
| 2025 | 3 | 6 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Biomedical imaging of bacteria and viruses15 Sep 2026US 12,734,260 B2Multi-Magnetics Incorporated
- Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography9 Jun 2026US 12,649,752 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods of suppressing delivery of exosomes to liver and spleen12 May 2026US 12,622,876 B2Lonza Sales AG
- Therapeutic use of mitochondria and combined mitochondrial agents14 Apr 2026US 12,600,800 B2Beth Israel Deaconess Medical Center, Inc.
- Cellular targeted label delivery system2 Dec 2025US 12,485,192 B2Cellis AG
- Epitope-Independent Pretargeted Therapy of Cancers Using Bacteria3 Sep 2026US 2026/0256964 A1University of Cincinnati
- Dental pulp-derived stem cells expressing sodium iodide symporter23 Jul 2026US 2026/0207674 A1JCR Pharmaceuticals Co., Ltd.
- Methods and materials for combining biologics with multiple chelators23 Jul 2026US 2026/0207796 A1Mayo Foundation for Medical Education and Research
- Use of exosome, complex comprising exosome, tracer, and preparation method thereof23 Apr 2026US 2026/0108642 A1National Atomic Research Insitute
- Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography5 Feb 2026US 2026/0035390 A1The United States of America, as represented by the Secretary, Department of Health and Human Services
Most cited
By later US patents
- Imaging protocols117US 8,644,910 B2Biosensors International Group, Ltd. · 2014
- Imaging tissue sites of inflammation82US 4,986,979 ANeoRx Corporation · 1991
- X-ray guided drug delivery68US 6,159,443 AVanderbilt University · 2000
- Glycoconjugates and methods56US 6,075,134 AThe Regents of the University of California · 2000
- Glycoconjugates and methods51US 6,458,937 B1The Regents of the University of California · 2002